Global GMP Testing Service Market Overview

Global GMP Testing Service Market was valued at USD 1.17 Billion in 2021 and is expected to reach USD 1.88 Billion by the year 2028, at a CAGR of 6.97% .

The growth of the GMP testing service market is majorly attributed to the rapidly growing pharmaceutical industry and the increasing trend in drug and device development. The growing burden of chronic diseases, the rising healthcare expenditure, and the upcoming patent expiration of blockbuster drugs are driving the trend of increasing drug and device development by biopharmaceutical companies, which, in turn, is expected to boost the growth of the market studied. Additionally, the increasing research and development activities by the drug manufacturers for the launch of innovative drugs with advanced features and strategic alliances are expected to drive the growth of the market studied. For instance, in March 2020, Existencia, an AI-based drug discovery company, entered a collaborative agreement with Diamond Light Source and Scripps Research for identifying COVID-19 antiviral therapies. Thus, these factors play a vital role in the growth of the GMP testing service market as GMP compliance is a major requirement for any drug and device development. Furthermore, with the increasing focus on the development of novel therapeutics to fight the COVID-19 pandemic by pharmaceutical development, there is an increasing demand for GMP testing services during the pandemic. Hence, all the aforementioned factors are expected to drive the growth of the studied market.

COVID-19 Impact on GMP Testing Service Market

At present, countries across the globe are facing a considerable threat from the COVID-19 pandemic. Many pharmaceutical and biotechnological companies are focusing their R&D activities on manufacturing novel therapeutics and vaccines to meet the increased demand for treating COVID-19 patients. Due to the situation, many pharmaceutical and biotechnological companies have been targeting their R&D departments on recognizing new molecules or leads for the treatment of this disease. Most of the economies have already accepted a vaccine for COVID-19. For instance, in December 2020, the World Health Organization (WHO) issued emergency use validation of the Pfizer/BioNTech COVID-19 mRNA vaccine globally. The increasing number of drugs, vaccines, diagnostics kits, and devices in various phases of development globally to combat the COVID-19 pandemic have resulted in surges in the demand for GMP testing services, which is very crucial at every step of the drug and device development and approval. However, the non-COVID-19 drug and devices development has seen a downward trend due to the postponement of clinical trials during the pandemic, which is expected to impact the market studied during the pandemic.

Market Dynamics And Factors

Drivers:

The Growing Pharmaceutical Industry

The pharmaceutical industries dedicate a large percentage of their budget for internal R&D processes, market expansion in developing countries, and technological advancements. The directly translates to increased expenditure on drug discovery. The production of Biopharmaceuticals has been growing not only by the introduction of novel therapeutics, but also by the introduction of generic Biopharmaceuticals or biosimilars. As many patents have been getting expired, there has been a significant focus on the production of generic pharmaceuticals. Pharma development involves the designing, building, and scaling-up of a process, to transform promising molecules synthesized in research labs into medicines for patient use. To test its purity and tenure, it consistently delivers safe and effective drug levels. The GMP testing service plays an important role; hence, the market is anticipated to grow promptly in the future years. Hence, owing to the growing investment in the pharmaceutical and medical device industry sector and research and development activities in both developed and developing countries, along with growing product approvals, the studied market is expected to propel over the forecast period.

Restraints:

GMP is a regulatory framework to ensure food, pharmaceutical, medical, and cosmetic products. They are consistently produced to provide quality standards, which are appropriate for their intended use and product specifications. These regulatory interventions can be circumvented only by proper research and manufacturing of the biological agents. Thereby, good manufacturing practices play a vital role in every aspect of product development and approvals. In this regard, a stringent regulatory framework has been imposed to prevent any further adverse events by the drugs or devices.

GMP practices are applied to conform to the guidelines recommended by agencies that control the authorization and licensing of the manufacture and sale of pharmaceuticals, devices, dietary supplements, etc. Vaccines and other regulated products undergo a meticulous review of laboratory and clinical data to ensure the safety, efficacy, purity, and potency of these products.

Moreover, the high cost associated with GMP compliance, along with the additional cost of labour, facilities improvements, equipment, sanitation, record-keeping, and other procedures important to GMP compliance, is expected to hinder the market growth.

Opportunities:

The GMP testing service market is expected to witness healthy growth in the coming years, owing to the increasing need of the drug and device manufacturers to compliant the good manufacturing practices in their day-to-day research and development activities, for the smooth approval of the target products by the regulatory bodies. As there has been an increasing focus on the development of numerous therapeutics and medical devices aimed toward providing effective treatment for varied chronic diseases by major pharmaceutical and biopharmaceutical companies, the need for GMP testing services is expected to grow in the future.

Additionally, most of the pharmaceutical companies are involved in outsourcing the GMP service to overcome the financial burden imposed by the product call-backs due to non-compliance with the GMP guidelines. For instance, in March 2021, the US FDA issued a Warning Letter to a Chinese manufacturer, Foshan Biours Biosciences Co. Ltd, of over-the-counter (OTC) drug products due to significant violations of cGMP regulations for finished pharmaceuticals. As per the warning letter, the company failed to follow and establish written procedures for cleaning and maintenance of equipment and a written stability testing program for the respective active ingredient. Thus, owing to the increasing demand for GMP compliance and the strategic initiatives taken by the key players of the studied market, the GMP testing service market is expected to witness steady growth in the future.

Market Segmentation

Segmentation Insights

Based on Service Type, the product validation testing segment dominated the studied market share with a revenue of USD 497.10 million in 2020 and is expected to register a CAGR over the forecast period. The increasing need for validation and verification of medical devices is leading to increased demand for product validation testing. Pharmaceutical products and medical devices need to follow a set of standards for the assurance of quality. Hence, from the aforementioned factors, the product validation testing segment is estimated to witness high growth over the forecast period. Thus, the bioanalytical testing segment is expected to grow significantly during the forecast period due to the aforementioned factors.

Based on End-Users, the pharmaceutical and biopharmaceutical companies segment dominated the studied market's share with a revenue of USD 844.85 million in 2020 and is expected to register a high CAGR over the forecast period. The novel drug development in the pharmaceutical and biopharmaceutical industry is expected to drive the segment's market growth over the forecast period. With growing research and development activities, there has been an increasing need for GMP testing in the pharmaceutical industry. The medical device manufacturers are creating a high demand for GMP testing services. The COVID-19 pandemic has also increased the demand for medical device GMP testing services as these services are vital in protecting consumers from poor quality, unsafe medical device products.

Regional Insights

The North American region of the market studied dominated with a revenue of USD 465.73 million in 2020, and it is expected to register the highest CAGR over the forecast period. The United States is expected to dominate the global GMP testing service market, throughout the forecast period, due to an increasing number of clinical studies, the presence of key market players, the growing pharmaceutical industry, and increasing drug and devices development.

Countries in the European region also have advanced healthcare and biopharmaceutical infrastructure, which helps set up operations for many companies. Thus, the aforementioned factors are expected to drive the regional market growth in upcoming years.

Some of the major factors driving the market growth in China include growing the pharmaceutical and medical industries and the increasing drug and devices development. The main factors attributing to the growth of the market are the growing biotech, pharmaceutical, and medical device industries in the APAC region. The increasing research and development activities are also expected to boost market growth.

Key Industry Developments

• In May 2021, PPD Inc. started a multipurpose clinical research laboratory in Suzhou, China. The new laboratory will help to provide services to Western and China-based pharmaceuticals and biotech companies controlling China research studies.

Players Covered in GMP Testing Service market are :

• Eurofins Scientific
• PPD Inc.
• Microchem Laboratory
• Sartorius AG
• North American Science Associates Inc.
• Laboratory Corporation of America Holdings (Covance Inc.)
• Sotera Health (Nelson Laboratories LLC)
• Almac Group
• Pace Analytical
• Wuxi AppTec
• Intertek Group PLC
• Charles River Laboratories and Others major players.

Chapter 1: Introduction
 1.1 Research Objectives
 1.2 Research Methodology
 1.3 Research Process
 1.4 Scope and Coverage
  1.4.1 Market Definition
  1.4.2 Key Questions Answered
 1.5 Market Segmentation

Chapter 2:Executive Summary

Chapter 3:Growth Opportunities By Segment
 3.1 By Type
 3.2 By End-User

Chapter 4: Market Landscape
 4.1 Porter's Five Forces Analysis
  4.1.1 Bargaining Power of Supplier
  4.1.2 Threat of New Entrants
  4.1.3 Threat of Substitutes
  4.1.4 Competitive Rivalry
  4.1.5 Bargaining Power Among Buyers
 4.2 Industry Value Chain Analysis
 4.3 Market Dynamics
  4.3.1 Drivers
  4.3.2 Restraints
  4.3.3 Opportunities
  4.5.4 Challenges
 4.4 Pestle Analysis
 4.5 Technological Roadmap
 4.6 Regulatory Landscape
 4.7 SWOT Analysis
 4.8 Price Trend Analysis
 4.9 Patent Analysis
 4.10 Analysis of the Impact of Covid-19
  4.10.1 Impact on the Overall Market
  4.10.2 Impact on the Supply Chain
  4.10.3 Impact on the Key Manufacturers
  4.10.4 Impact on the Pricing

Chapter 5: GMP Testing Service Market by Type
 5.1 GMP Testing Service Market Overview Snapshot and Growth Engine
 5.2 GMP Testing Service Market Overview
 5.3 Product Validation Testing
  5.3.1 Introduction and Market Overview
  5.3.2 Historic and Forecasted Market Size (2016-2028F)
  5.3.3 Key Market Trends, Growth Factors and Opportunities
  5.3.4 Product Validation Testing: Grographic Segmentation
 5.4 Bioanalytical Services
  5.4.1 Introduction and Market Overview
  5.4.2 Historic and Forecasted Market Size (2016-2028F)
  5.4.3 Key Market Trends, Growth Factors and Opportunities
  5.4.4 Bioanalytical Services: Grographic Segmentation
 5.5 Packaging
  5.5.1 Introduction and Market Overview
  5.5.2 Historic and Forecasted Market Size (2016-2028F)
  5.5.3 Key Market Trends, Growth Factors and Opportunities
  5.5.4 Packaging: Grographic Segmentation
 5.6 Shelf-Life Testing
  5.6.1 Introduction and Market Overview
  5.6.2 Historic and Forecasted Market Size (2016-2028F)
  5.6.3 Key Market Trends, Growth Factors and Opportunities
  5.6.4 Shelf-Life Testing: Grographic Segmentation
 5.7 Others
  5.7.1 Introduction and Market Overview
  5.7.2 Historic and Forecasted Market Size (2016-2028F)
  5.7.3 Key Market Trends, Growth Factors and Opportunities
  5.7.4 Others: Grographic Segmentation

Chapter 6: GMP Testing Service Market by End-User
 6.1 GMP Testing Service Market Overview Snapshot and Growth Engine
 6.2 GMP Testing Service Market Overview
 6.3 Pharmaceutical & Biopharmaceutical Companies
  6.3.1 Introduction and Market Overview
  6.3.2 Historic and Forecasted Market Size (2016-2028F)
  6.3.3 Key Market Trends, Growth Factors and Opportunities
  6.3.4 Pharmaceutical & Biopharmaceutical Companies: Grographic Segmentation
 6.4 Medical Devices Company
  6.4.1 Introduction and Market Overview
  6.4.2 Historic and Forecasted Market Size (2016-2028F)
  6.4.3 Key Market Trends, Growth Factors and Opportunities
  6.4.4 Medical Devices Company: Grographic Segmentation

Chapter 7: Company Profiles and Competitive Analysis
 7.1 Competitive Landscape
  7.1.1 Competitive Positioning
  7.1.2 GMP Testing Service Sales and Market Share By Players
  7.1.3 Industry BCG Matrix
  7.1.4 Ansoff Matrix
  7.1.5 GMP Testing Service Industry Concentration Ratio (CR5 and HHI)
  7.1.6 Top 5 GMP Testing Service Players Market Share
  7.1.7 Mergers and Acquisitions
  7.1.8 Business Strategies By Top Players
 7.2 EUROFINS SCIENTIFIC
  7.2.1 Company Overview
  7.2.2 Key Executives
  7.2.3 Company Snapshot
  7.2.4 Operating Business Segments
  7.2.5 Product Portfolio
  7.2.6 Business Performance
  7.2.7 Key Strategic Moves and Recent Developments
  7.2.8 SWOT Analysis
 7.3 PPD INC.
 7.4 MICROCHEM LABORATORY
 7.5 SARTORIUS AG
 7.6 NORTH AMERICAN SCIENCE ASSOCIATES INC.
 7.7 LABORATORY CORPORATION OF AMERICA HOLDINGS (COVANCE INC.)
 7.8 SOTERA HEALTH (NELSON LABORATORIES LLC)
 7.9 ALMAC GROUP
 7.10 PACE ANALYTICAL
 7.11 WUXI APPTEC
 7.12 INTERTEK GROUP PLC
 7.13 CHARLES RIVER LABORATORIES
 7.14 OTHER MAJOR PLAYERS

Chapter 8: Global GMP Testing Service Market Analysis, Insights and Forecast, 2016-2028
 8.1 Market Overview
 8.2 Historic and Forecasted Market Size By Type
  8.2.1 Product Validation Testing
  8.2.2 Bioanalytical Services
  8.2.3 Packaging
  8.2.4 Shelf-Life Testing
  8.2.5 Others
 8.3 Historic and Forecasted Market Size By End-User
  8.3.1 Pharmaceutical & Biopharmaceutical Companies
  8.3.2 Medical Devices Company

Chapter 9: North America GMP Testing Service Market Analysis, Insights and Forecast, 2016-2028
 9.1 Key Market Trends, Growth Factors and Opportunities
 9.2 Impact of Covid-19
 9.3 Key Players
 9.4 Key Market Trends, Growth Factors and Opportunities
 9.4 Historic and Forecasted Market Size By Type
  9.4.1 Product Validation Testing
  9.4.2 Bioanalytical Services
  9.4.3 Packaging
  9.4.4 Shelf-Life Testing
  9.4.5 Others
 9.5 Historic and Forecasted Market Size By End-User
  9.5.1 Pharmaceutical & Biopharmaceutical Companies
  9.5.2 Medical Devices Company
 9.6 Historic and Forecast Market Size by Country
  9.6.1 U.S.
  9.6.2 Canada
  9.6.3 Mexico

Chapter 10: Europe GMP Testing Service Market Analysis, Insights and Forecast, 2016-2028
 10.1 Key Market Trends, Growth Factors and Opportunities
 10.2 Impact of Covid-19
 10.3 Key Players
 10.4 Key Market Trends, Growth Factors and Opportunities
 10.4 Historic and Forecasted Market Size By Type
  10.4.1 Product Validation Testing
  10.4.2 Bioanalytical Services
  10.4.3 Packaging
  10.4.4 Shelf-Life Testing
  10.4.5 Others
 10.5 Historic and Forecasted Market Size By End-User
  10.5.1 Pharmaceutical & Biopharmaceutical Companies
  10.5.2 Medical Devices Company
 10.6 Historic and Forecast Market Size by Country
  10.6.1 Germany
  10.6.2 U.K.
  10.6.3 France
  10.6.4 Italy
  10.6.5 Russia
  10.6.6 Spain
  10.6.7 Rest of Europe

Chapter 11: Asia-Pacific GMP Testing Service Market Analysis, Insights and Forecast, 2016-2028
 11.1 Key Market Trends, Growth Factors and Opportunities
 11.2 Impact of Covid-19
 11.3 Key Players
 11.4 Key Market Trends, Growth Factors and Opportunities
 11.4 Historic and Forecasted Market Size By Type
  11.4.1 Product Validation Testing
  11.4.2 Bioanalytical Services
  11.4.3 Packaging
  11.4.4 Shelf-Life Testing
  11.4.5 Others
 11.5 Historic and Forecasted Market Size By End-User
  11.5.1 Pharmaceutical & Biopharmaceutical Companies
  11.5.2 Medical Devices Company
 11.6 Historic and Forecast Market Size by Country
  11.6.1 China
  11.6.2 India
  11.6.3 Japan
  11.6.4 Singapore
  11.6.5 Australia
  11.6.6 New Zealand
  11.6.7 Rest of APAC

Chapter 12: Middle East & Africa GMP Testing Service Market Analysis, Insights and Forecast, 2016-2028
 12.1 Key Market Trends, Growth Factors and Opportunities
 12.2 Impact of Covid-19
 12.3 Key Players
 12.4 Key Market Trends, Growth Factors and Opportunities
 12.4 Historic and Forecasted Market Size By Type
  12.4.1 Product Validation Testing
  12.4.2 Bioanalytical Services
  12.4.3 Packaging
  12.4.4 Shelf-Life Testing
  12.4.5 Others
 12.5 Historic and Forecasted Market Size By End-User
  12.5.1 Pharmaceutical & Biopharmaceutical Companies
  12.5.2 Medical Devices Company
 12.6 Historic and Forecast Market Size by Country
  12.6.1 Turkey
  12.6.2 Saudi Arabia
  12.6.3 Iran
  12.6.4 UAE
  12.6.5 Africa
  12.6.6 Rest of MEA

Chapter 13: South America GMP Testing Service Market Analysis, Insights and Forecast, 2016-2028
 13.1 Key Market Trends, Growth Factors and Opportunities
 13.2 Impact of Covid-19
 13.3 Key Players
 13.4 Key Market Trends, Growth Factors and Opportunities
 13.4 Historic and Forecasted Market Size By Type
  13.4.1 Product Validation Testing
  13.4.2 Bioanalytical Services
  13.4.3 Packaging
  13.4.4 Shelf-Life Testing
  13.4.5 Others
 13.5 Historic and Forecasted Market Size By End-User
  13.5.1 Pharmaceutical & Biopharmaceutical Companies
  13.5.2 Medical Devices Company
 13.6 Historic and Forecast Market Size by Country
  13.6.1 Brazil
  13.6.2 Argentina
  13.6.3 Rest of SA

Chapter 14 Investment Analysis

Chapter 15 Analyst Viewpoint and Conclusion

LIST OF TABLES

TABLE 001. EXECUTIVE SUMMARY
TABLE 002. GMP TESTING SERVICE MARKET BARGAINING POWER OF SUPPLIERS
TABLE 003. GMP TESTING SERVICE MARKET BARGAINING POWER OF CUSTOMERS
TABLE 004. GMP TESTING SERVICE MARKET COMPETITIVE RIVALRY
TABLE 005. GMP TESTING SERVICE MARKET THREAT OF NEW ENTRANTS
TABLE 006. GMP TESTING SERVICE MARKET THREAT OF SUBSTITUTES
TABLE 007. GMP TESTING SERVICE MARKET BY TYPE
TABLE 008. PRODUCT VALIDATION TESTING MARKET OVERVIEW (2016-2028)
TABLE 009. BIOANALYTICAL SERVICES MARKET OVERVIEW (2016-2028)
TABLE 010. PACKAGING MARKET OVERVIEW (2016-2028)
TABLE 011. SHELF-LIFE TESTING MARKET OVERVIEW (2016-2028)
TABLE 012. OTHERS MARKET OVERVIEW (2016-2028)
TABLE 013. GMP TESTING SERVICE MARKET BY END-USER
TABLE 014. PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES MARKET OVERVIEW (2016-2028)
TABLE 015. MEDICAL DEVICES COMPANY MARKET OVERVIEW (2016-2028)
TABLE 016. NORTH AMERICA GMP TESTING SERVICE MARKET, BY TYPE (2016-2028)
TABLE 017. NORTH AMERICA GMP TESTING SERVICE MARKET, BY END-USER (2016-2028)
TABLE 018. N GMP TESTING SERVICE MARKET, BY COUNTRY (2016-2028)
TABLE 019. EUROPE GMP TESTING SERVICE MARKET, BY TYPE (2016-2028)
TABLE 020. EUROPE GMP TESTING SERVICE MARKET, BY END-USER (2016-2028)
TABLE 021. GMP TESTING SERVICE MARKET, BY COUNTRY (2016-2028)
TABLE 022. ASIA PACIFIC GMP TESTING SERVICE MARKET, BY TYPE (2016-2028)
TABLE 023. ASIA PACIFIC GMP TESTING SERVICE MARKET, BY END-USER (2016-2028)
TABLE 024. GMP TESTING SERVICE MARKET, BY COUNTRY (2016-2028)
TABLE 025. MIDDLE EAST & AFRICA GMP TESTING SERVICE MARKET, BY TYPE (2016-2028)
TABLE 026. MIDDLE EAST & AFRICA GMP TESTING SERVICE MARKET, BY END-USER (2016-2028)
TABLE 027. GMP TESTING SERVICE MARKET, BY COUNTRY (2016-2028)
TABLE 028. SOUTH AMERICA GMP TESTING SERVICE MARKET, BY TYPE (2016-2028)
TABLE 029. SOUTH AMERICA GMP TESTING SERVICE MARKET, BY END-USER (2016-2028)
TABLE 030. GMP TESTING SERVICE MARKET, BY COUNTRY (2016-2028)
TABLE 031. EUROFINS SCIENTIFIC: SNAPSHOT
TABLE 032. EUROFINS SCIENTIFIC: BUSINESS PERFORMANCE
TABLE 033. EUROFINS SCIENTIFIC: PRODUCT PORTFOLIO
TABLE 034. EUROFINS SCIENTIFIC: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 034. PPD INC.: SNAPSHOT
TABLE 035. PPD INC.: BUSINESS PERFORMANCE
TABLE 036. PPD INC.: PRODUCT PORTFOLIO
TABLE 037. PPD INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 037. MICROCHEM LABORATORY: SNAPSHOT
TABLE 038. MICROCHEM LABORATORY: BUSINESS PERFORMANCE
TABLE 039. MICROCHEM LABORATORY: PRODUCT PORTFOLIO
TABLE 040. MICROCHEM LABORATORY: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 040. SARTORIUS AG: SNAPSHOT
TABLE 041. SARTORIUS AG: BUSINESS PERFORMANCE
TABLE 042. SARTORIUS AG: PRODUCT PORTFOLIO
TABLE 043. SARTORIUS AG: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 043. NORTH AMERICAN SCIENCE ASSOCIATES INC.: SNAPSHOT
TABLE 044. NORTH AMERICAN SCIENCE ASSOCIATES INC.: BUSINESS PERFORMANCE
TABLE 045. NORTH AMERICAN SCIENCE ASSOCIATES INC.: PRODUCT PORTFOLIO
TABLE 046. NORTH AMERICAN SCIENCE ASSOCIATES INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 046. LABORATORY CORPORATION OF AMERICA HOLDINGS (COVANCE INC.): SNAPSHOT
TABLE 047. LABORATORY CORPORATION OF AMERICA HOLDINGS (COVANCE INC.): BUSINESS PERFORMANCE
TABLE 048. LABORATORY CORPORATION OF AMERICA HOLDINGS (COVANCE INC.): PRODUCT PORTFOLIO
TABLE 049. LABORATORY CORPORATION OF AMERICA HOLDINGS (COVANCE INC.): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 049. SOTERA HEALTH (NELSON LABORATORIES LLC): SNAPSHOT
TABLE 050. SOTERA HEALTH (NELSON LABORATORIES LLC): BUSINESS PERFORMANCE
TABLE 051. SOTERA HEALTH (NELSON LABORATORIES LLC): PRODUCT PORTFOLIO
TABLE 052. SOTERA HEALTH (NELSON LABORATORIES LLC): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 052. ALMAC GROUP: SNAPSHOT
TABLE 053. ALMAC GROUP: BUSINESS PERFORMANCE
TABLE 054. ALMAC GROUP: PRODUCT PORTFOLIO
TABLE 055. ALMAC GROUP: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 055. PACE ANALYTICAL: SNAPSHOT
TABLE 056. PACE ANALYTICAL: BUSINESS PERFORMANCE
TABLE 057. PACE ANALYTICAL: PRODUCT PORTFOLIO
TABLE 058. PACE ANALYTICAL: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 058. WUXI APPTEC: SNAPSHOT
TABLE 059. WUXI APPTEC: BUSINESS PERFORMANCE
TABLE 060. WUXI APPTEC: PRODUCT PORTFOLIO
TABLE 061. WUXI APPTEC: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 061. INTERTEK GROUP PLC: SNAPSHOT
TABLE 062. INTERTEK GROUP PLC: BUSINESS PERFORMANCE
TABLE 063. INTERTEK GROUP PLC: PRODUCT PORTFOLIO
TABLE 064. INTERTEK GROUP PLC: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 064. CHARLES RIVER LABORATORIES: SNAPSHOT
TABLE 065. CHARLES RIVER LABORATORIES: BUSINESS PERFORMANCE
TABLE 066. CHARLES RIVER LABORATORIES: PRODUCT PORTFOLIO
TABLE 067. CHARLES RIVER LABORATORIES: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 067. OTHER MAJOR PLAYERS: SNAPSHOT
TABLE 068. OTHER MAJOR PLAYERS: BUSINESS PERFORMANCE
TABLE 069. OTHER MAJOR PLAYERS: PRODUCT PORTFOLIO
TABLE 070. OTHER MAJOR PLAYERS: KEY STRATEGIC MOVES AND DEVELOPMENTS

LIST OF FIGURES

FIGURE 001. YEARS CONSIDERED FOR ANALYSIS
FIGURE 002. SCOPE OF THE STUDY
FIGURE 003. GMP TESTING SERVICE MARKET OVERVIEW BY REGIONS
FIGURE 004. PORTER'S FIVE FORCES ANALYSIS
FIGURE 005. BARGAINING POWER OF SUPPLIERS
FIGURE 006. COMPETITIVE RIVALRYFIGURE 007. THREAT OF NEW ENTRANTS
FIGURE 008. THREAT OF SUBSTITUTES
FIGURE 009. VALUE CHAIN ANALYSIS
FIGURE 010. PESTLE ANALYSIS
FIGURE 011. GMP TESTING SERVICE MARKET OVERVIEW BY TYPE
FIGURE 012. PRODUCT VALIDATION TESTING MARKET OVERVIEW (2016-2028)
FIGURE 013. BIOANALYTICAL SERVICES MARKET OVERVIEW (2016-2028)
FIGURE 014. PACKAGING MARKET OVERVIEW (2016-2028)
FIGURE 015. SHELF-LIFE TESTING MARKET OVERVIEW (2016-2028)
FIGURE 016. OTHERS MARKET OVERVIEW (2016-2028)
FIGURE 017. GMP TESTING SERVICE MARKET OVERVIEW BY END-USER
FIGURE 018. PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES MARKET OVERVIEW (2016-2028)
FIGURE 019. MEDICAL DEVICES COMPANY MARKET OVERVIEW (2016-2028)
FIGURE 020. NORTH AMERICA GMP TESTING SERVICE MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 021. EUROPE GMP TESTING SERVICE MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 022. ASIA PACIFIC GMP TESTING SERVICE MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 023. MIDDLE EAST & AFRICA GMP TESTING SERVICE MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 024. SOUTH AMERICA GMP TESTING SERVICE MARKET OVERVIEW BY COUNTRY (2016-2028)